Showing results (131-140 of 761) with videos related to
Sort By:
Pageof 77
Transplantation|February 24, 2007
DnIKK2-transfected dendritic cells induce a novel population of inducible nitric oxide synthase-expressing CD4+CD25- cells with tolerogenic propertiesSistiana Aiello, Paola Cassis, Linda Cassis, et al.Transplantation|November 9, 2007
Sirolimus versus cyclosporine therapy increases circulating regulatory T cells, but does not protect renal transplant patients given alemtuzumab induction from chronic allograft injuryPiero Ruggenenti, Norberto Perico, Eliana Gotti, et al.Frontiers in Immunology|July 7, 2025
C3d-targeted complement inhibitors to correct complement dysregulation in aHUS patientsValeria Guaschino, Donata Santarsiero, Sara Gastoldi, et al.Kidney International|February 10, 2012
Erythropoietin, but not the correction of anemia alone, protects from chronic kidney allograft injuryPaola Cassis, Lorenzo Gallon, Ariela Benigni, et al.Diabetes|June 5, 2013
ADAMTS13 predicts renal and cardiovascular events in type 2 diabetic patients and response to therapyErica Rurali, Marina Noris, Antonietta Chianca, et al.Kidney International|August 13, 2010
Sirolimus for calcineurin inhibitors in organ transplantation: contraPaolo Cravedi, Piero Ruggenenti, Giuseppe RemuzziJournal of the American Society of Nephrology : JASN|December 25, 2003
Transplant renal artery stenosisSimona Bruno, Giuseppe Remuzzi, Piero RuggenentiCurrent Opinion in Nephrology and Hypertension|April 13, 2006
Progression of chronic kidney disease: insights from animal modelsCarla Zoja, Mauro Abbate, Giuseppe RemuzziHuman Immunology|December 31, 2017
Mesenchymal stromal cells for tolerance induction in organ transplantationFederica Casiraghi, Norberto Perico, Giuseppe RemuzziScience and Engineering Ethics|October 2, 2002
Conflict of interest as seen from a researcher's perspectiveArrigo Schieppati, Norberto Perico, Giuseppe RemuzziPageof 77